Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-05-02 | New | $250,000 | $250,000 | Equity Only | 06c | SEC link |
| 2022-05-17 | New | $3,833,592 | $3,833,592 | Equity Only | 06b | SEC link |
| 2021-02-24 | New | $3,253,368 | $3,253,368 | Equity Only | 06b | SEC link |
| 2019-04-17 | New | $580,500 | $580,500 | Equity Only | 06b | SEC link |
| 2019-03-11 | New | $8,056,505 | $8,056,505 | Equity Only | 06b | SEC link |
| 2017-03-07 | New | $4,175,557 | $4,175,557 | Equity Only | 06b | SEC link |
| 2016-10-20 | Amended | $10,049,743 | $2,649,290 | Equity Only | 06b | SEC link |
| 2016-02-23 | New | $7,400,453 | $7,400,453 | Equity Only | 06b | SEC link |
| 2015-07-02 | Amended | $4,854,850 | $4,054,850 | Equity and Debt | 06b | SEC link |
| 2015-04-17 | New | $800,000 | $800,000 | Equity and Debt | 06b | SEC link |
| Name | Role |
|---|---|
| Johannes Czernin | Director |
| Jean B. De Kernion | Director, Executive |
| Timothy Donahue, M.D. | Director |
| Laurent Dubois | Director |
| Louis L. Gonda | Director |
| Johanna Holldack | Director, Executive |
| Nathan Mata | Executive |
| Carl Mc Kinzie | Director |
| R. Boyd Quinnell | Director |
| Caius Radu | Director |
| Lynne Rollins | Executive |
| Kenneth A. Schultz, M.D. | Director, Executive |
| John Stretton | Executive |
| Owen Witte, M.D. | Director |